I am a board-certified general surgeon specializing in surgical oncology with a clinical expertise in melanoma and soft tissue sarcoma. I work closely with the patient and the comprehensive team of physicians to customize treatment plans for each individual.
In my research, I am investigating new ways to allow the immune system to fight cancer. I am also involved in clinical trials aimed at defining the role of current therapies and improving outcomes through novel new treatments. I am currently the principal investigator (PI) of a Phase II trial investigating the addition of systemic ipilimumab to isolated limb infusion for melanoma in transit disease. I am also the Memorial Sloan Kettering PI of the multi-center MSLT-II trial. This trial randomizes patients with a positive sentinel lymph node to completon lymph node dissection versus ultrasound surveillance of the lymph nodes.
- Clinical Expertise: Melanoma; Soft Tissue Sarcoma; Merkel Cell Carcinoma
- Languages Spoken: English; Spanish
- Education: MD, University of Vermont College of Medicine; PhD, Yale University
- Residencies: Yale-New Haven Hospital
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Surgery
Selected Book Chapters
“Salivary gland tumors.” Ariyan S, Narayan D, Ariyan C. In: Plastic Surgery, Volume 5. 2nd ed. Philadelphia: WB Saunders; 2006.
“Surgical management of soft tissue sarcoma: histologic type and grade guide surgical planning and integration of multimodality therapy.” Ariyan C, Singer S. In: Modern Soft Tissue Pathology. New York: Cambridge UP; 2010.
“Surgical management of soft tissue sarcoma in the geriatric population.” Ariyan C, Brennan M. In: Principles and Practice of Geriatric Surgery. 2nd ed. New York: Springer; 2011.
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.